The journalist's source for JAX-related news and information.
Newly re-funded JAX center is empowering innovative approaches to aging research.
The Maine Cancer Genomics Initiative (MCGI), a collaboration aimed at making the latest personalized medicine available to cancer patients throughout Maine, will now bring new precision oncology clinical trials to the state, support access to targeted therapies for patients not eligible for trials, and develop novel technology to enhance genomic education and genetic services through online platforms.
Funding will support scientific research and training activities in the field of neurodegenerative diseases of the eye, including graduate and postdoctoral fellowship training and research projects in glaucoma, age-related macular degeneration, and ocular signs of Alzheimer’s disease.
New five-year NIH grant totaling $10.6M funds JAX center to fast-track treatment-focused research for rare genetic disorders.